160 related articles for article (PubMed ID: 20375710)
21. Polymorphisms of xenobiotic metabolizing genes in oropharyngeal carcinoma.
Amador AG; Righi PD; Radpour S; Everett ET; Weisberger E; Langer M; Eckert GJ; Christen AG; Campbell S; Summerlin DJ; Reynolds N; Hartsfield JK
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):440-5. PubMed ID: 12029283
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.
Pande M; Amos CI; Osterwisch DR; Chen J; Lynch PM; Broaddus R; Frazier ML
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2393-401. PubMed ID: 18768509
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
Gresner P; Gromadzinska J; Wasowicz W
Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
[TBL] [Abstract][Full Text] [Related]
24. Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer.
Turner F; Smith G; Sachse C; Lightfoot T; Garner RC; Wolf CR; Forman D; Bishop DT; Barrett JH
Int J Cancer; 2004 Nov; 112(2):259-64. PubMed ID: 15352038
[TBL] [Abstract][Full Text] [Related]
25. Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
Nisa H; Budhathoki S; Morita M; Toyomura K; Nagano J; Ohnaka K; Kono S; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
Mol Carcinog; 2013 Aug; 52(8):619-26. PubMed ID: 22415791
[TBL] [Abstract][Full Text] [Related]
26. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.
Malik MA; Upadhyay R; Mittal RD; Zargar SA; Mittal B
Nutr Cancer; 2010; 62(6):734-42. PubMed ID: 20661821
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in xenobiotic metabolism-related genes in patients with hepatocellular carcinoma: a case-control study.
Ferreira GD; Fernandes GMM; Penteado C; Cória VR; Galbiatti-Dias ALDS; Russo A; Castanhole-Nunes MMU; Silva RFD; Silva RCMAD; Pavarino ÉC; Torreglosa Ruiz Cintra M; Goloni-Bertollo EM
Xenobiotica; 2021 Jun; 51(6):737-744. PubMed ID: 33896378
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group.
Bartsch H; Malaveille C; Lowenfels AB; Maisonneuve P; Hautefeuille A; Boyle P
Eur J Cancer Prev; 1998 Jun; 7(3):215-23. PubMed ID: 9696930
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility.
Hengstler JG; Arand M; Herrero ME; Oesch F
Recent Results Cancer Res; 1998; 154():47-85. PubMed ID: 10026993
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
Siraj AK; Ibrahim M; Al-Rasheed M; Abubaker J; Bu R; Siddiqui SU; Al-Dayel F; Al-Sanea O; Al-Nuaim A; Uddin S; Al-Kuraya K
BMC Med Genet; 2008 Jul; 9():61. PubMed ID: 18601742
[TBL] [Abstract][Full Text] [Related]
31. Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer.
Gilsing AM; Berndt SI; Ruder EH; Graubard BI; Ferrucci LM; Burdett L; Weissfeld JL; Cross AJ; Sinha R
Carcinogenesis; 2012 Jul; 33(7):1332-9. PubMed ID: 22552404
[TBL] [Abstract][Full Text] [Related]
32. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
Habalová V; Salagovic J; Kalina I; Stubna J
Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
34. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma.
Huang WY; Chatterjee N; Chanock S; Dean M; Yeager M; Schoen RE; Hou LF; Berndt SI; Yadavalli S; Johnson CC; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):152-7. PubMed ID: 15668489
[TBL] [Abstract][Full Text] [Related]
35. High order interactions of xenobiotic metabolizing genes and P53 codon 72 polymorphisms in acute leukemia.
Chauhan PS; Ihsan R; Mishra AK; Yadav DS; Saluja S; Mittal V; Saxena S; Kapur S
Environ Mol Mutagen; 2012 Oct; 53(8):619-30. PubMed ID: 22930568
[TBL] [Abstract][Full Text] [Related]
36. Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population.
Zidzik J; Slabá E; Joppa P; Kluchová Z; Dorková Z; Skyba P; Habalová V; Salagovic J; Tkácová R
Croat Med J; 2008 Apr; 49(2):182-91. PubMed ID: 18461673
[TBL] [Abstract][Full Text] [Related]
37. Genetic Polymorphisms of Xenobiotic Metabolizing Genes (GSTM1, GSTT1, GSTP1), Gene-Gene Interaction with Association to Lung Cancer Risk in North India; A Case Control Study.
Ritambhara ; Tiwari S; Vijayaraghavalu S; Kumar M
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2707-2714. PubMed ID: 31554367
[TBL] [Abstract][Full Text] [Related]
38. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.
Boccia S; Cadoni G; Sayed-Tabatabaei FA; Volante M; Arzani D; De Lauretis A; Cattel C; Almadori G; van Duijn CM; Paludetti G; Ricciardi G
J Cancer Res Clin Oncol; 2008 Jan; 134(1):93-100. PubMed ID: 17611777
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population.
Al-Dayel F; Al-Rasheed M; Ibrahim M; Bu R; Bavi P; Abubaker J; Al-Jomah N; Mohamed GH; Moorji A; Uddin S; Siraj AK; Al-Kuraya K
Leuk Lymphoma; 2008 Jan; 49(1):122-9. PubMed ID: 18203021
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
